Guard Therapeutics (Sweden) Story

GUARD Stock  SEK 30.60  1.00  3.38%   
Slightly above 55% of Guard Therapeutics' private investors are presently thinking to get in. The analysis of current outlook of investing in Guard Therapeutics International suggests that some traders are interested regarding Guard Therapeutics' prospects. Guard Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Guard Therapeutics International. The current market sentiment, together with Guard Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Guard Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Guard Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Guard daily returns and investor perception about the current price of Guard Therapeutics International as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Guard Therapeutics International.

Guard Therapeutics Latest Timeline

Guard Therapeutics is currently traded for 30.60on Stockholm Exchange of Sweden. About 30.0% of the company shares are held by company insiders. The book value of Guard Therapeutics was currently reported as 0.3. The company recorded a loss per share of 0.34. Guard Therapeutics had not issued any dividends in recent years. The entity had 50:1 split on the 15th of December 2023.
Check out Guard Therapeutics Hype Analysis, Guard Therapeutics Correlation and Guard Therapeutics Performance.
Note that the Guard Therapeutics information on this page should be used as a complementary analysis to other Guard Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Guard Stock analysis

When running Guard Therapeutics' price analysis, check to measure Guard Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guard Therapeutics is operating at the current time. Most of Guard Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guard Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guard Therapeutics' price. Additionally, you may evaluate how the addition of Guard Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
CEOs Directory
Screen CEOs from public companies around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Please note, there is a significant difference between Guard Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Guard Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guard Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.